A major review of the data behind the anti- flu drugs Tamiflu and Relenza was released earlier this month. Governments worldwide spent billions of dollars stockpiling these drugs (Tamiflu particular) to release in case of a pandemic. This was based on them reducing transmission of the virus, reducing complications and shortening the course of the illness.
Small problem – the drugs do not do what has been claimed. I have written a piece for Fairfax Australian news websites. Click here to read.